Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC in hospitalized COVID-19 patients
NCT04455243Phase 3Unknown
- Start
- Aug 2020
- Primary completion
- Aug 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of acetylcysteine in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04455243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04455243.